The mTOR Signalling Pathway in Human Cancer

By Pópulo Helena   Lopes José Manuel   Soares Paula  

International Journal of Molecular Sciences, Vol. 13, Iss. 2, 2012-02 ,pp. : 1886-1918

MDPI

Access to resources Recommend Favorite

mTOR Cross-Talk in Cancer and Potential for Combination Therapy

By Conciatori Fabiana   Ciuffreda Ludovica   Bazzichetto Chiara   Falcone Italia   Pilotto Sara   Bria Emilio   Cognetti Francesco   Milella Michele  

Cancers, Vol. 10, Iss. 1, 2018-01 ,pp. : 23-23

MDPI

Access to resources Recommend Favorite

mTOR Inhibition Induces EGFR Feedback Activation in Association with Its Resistance to Human Pancreatic Cancer

By Wei Feng   Zhang Yandong   Geng Li   Zhang Ping   Wang Guangyi   Liu Yan  

International Journal of Molecular Sciences, Vol. 16, Iss. 2, 2015-02 ,pp. : 3267-3282

MDPI

Access to resources Recommend Favorite

Oncogenic Signalling through Mechanistic Target of Rapamycin (mTOR): A Driver of Metabolic Transformation and Cancer Progression

By Rad Ellie   Murray James T.   Tee Andrew R.  

Cancers, Vol. 10, Iss. 1, 2018-01 ,pp. : 5-5

MDPI

Access to resources Recommend Favorite

Targeting the Mammalian Target of Rapamycin (mTOR) in Cancer Therapy: Lessons from Past and Future Perspectives

By Dufour Marc   Dormond-Meuwly Anne   Demartines Nicolas   Dormond Olivier  

Cancers, Vol. 3, Iss. 2, 2011-05 ,pp. : 2478-2500

MDPI

Access to resources Recommend Favorite